 | NovoCure Limited | |||
| NMS : NVCR || Location: Jersey | ||||
$12.05-0.41 (-3.29%) |
1.36 M | 12.04 - 12.45 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 5.010 M |
| March 15, 2024 | 5.541 M |
| Feb. 29, 2024 | 5.641 M |
| Feb. 15, 2024 | 6.133 M |
| Jan. 31, 2024 | 5.770 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.53 | -0.45 | 15.40% |
| 09/30/2023 | -0.54 | -0.46 | 14.10% |
| 06/30/2023 | -0.51 | -0.54 | -5.80% |
| 03/31/2023 | -0.33 | -0.50 | -51.47% |
| 12/31/2022 | -0.31 | -0.36 | -15.72% |
NVCR Basic Data
| Sector | Healthcare | Industry | Medical Devices |
| Shares Outstanding | 107.093M | Shares Float | 95.915M |
| Short Float | 5.010M | Market Cap | 1334.38M |
| Institution ownership | 85.87% | Insider ownership | 1.667% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.95 | Forward EPS | -1.83 |